Search

Author/Creator Taylor, Clarke

1. RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. (4th November 2015)

Authors:
Hu, Xiao; Moisan, Jacques; Majchrzak, Kinga; Lesch, Chuck; Wang, Yahong; Sanchez, Brian; Liu, Xikui; Morgan, Rodney; Mertz, David; Bousley, Dick; van Huis, Chad; Skalitzky, Don; Taylor, Clarke; Aicher, Thomas; Toogood, Peter; Zou, Weiping; Glick, Gary; Paulos, Chrystal; Carter, Laura
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. Issue 2 (December 2015)

Authors:
Hu, Xiao; Moisan, Jacques; Majchrzak, Kinga; Lesch, Chuck; Wang, Yahong; Sanchez, Brian; Liu, Xikui; Morgan, Rodney; Mertz, David; Bousley, Dick; van Huis, Chad; Skalitzky, Don; Taylor, Clarke; Aicher, Thomas; Toogood, Peter; Zou, Weiping; Glick, Gary; Paulos, Chrystal; Carter, Laura
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. (1st December 2016)

Authors:
Hu, Xiao; Liu, Xikui; Moisan, Jacques; Wang, Yahong; Lesch, Charles A.; Spooner, Chauncey; Morgan, Rodney W.; Zawidzka, Elizabeth M.; Mertz, David; Bousley, Dick; Majchrzak, Kinga; Kryczek, Ilona; Taylor, Clarke; Van Huis, Chad; Skalitzky, Don; Hurd, Alexander; Aicher, Thomas D.; Toogood, Peter L...
Journal:
Oncoimmunology
Issue:
Volume 5:Number 12(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗